Nanotech Investing Soleno Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025, at 4:30 PM ET
Nanotech Investing Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
